RxSight (RXST) Capital Expenditures (2020 - 2026)

RxSight (RXST) has 7 years of Capital Expenditures data on file, last reported at $170000.0 in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 70.43% year-over-year to $170000.0; the trailing twelve-month figure through Mar 2026 stood at $16000.0 (down 99.72% YoY), and the FY2025 full-year result was $421000.0, down 92.26% from the prior year.
• Capital Expenditures for Q1 2026 stood at $170000.0, up from -$2.3 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $5.0 million in Q4 2024 and bottomed at -$2.3 million in Q4 2025.
• The 5-year median for Capital Expenditures is $343000.0 (2024), against an average of $655529.4.
• The widest annual swing landed in 2022, when Capital Expenditures plunged 574.52%; it then jumped 1389.63% in 2025.
• A 5-year view of Capital Expenditures shows it stood at -$1.7 million in 2022, then soared by 191.86% to $1.6 million in 2023, then jumped by 217.22% to $5.0 million in 2024, then sank by 145.02% to -$2.3 million in 2025, then soared by 107.48% to $170000.0 in 2026.
• The last three Capital Expenditures figures came in at $170000.0 (Q1 2026), -$2.3 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

Peer Comparison